RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arcadia Biosciences Stock

Arcadia Biosciences Revenue 2024

Arcadia Biosciences Revenue

5.36 M USD

Ticker

RKDA

ISIN

US0390142042

WKN

A2JSFW

In 2024, Arcadia Biosciences's sales reached 5.36 M USD, a 0.53% difference from the 5.33 M USD sales recorded in the previous year.

The Arcadia Biosciences Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e7.6532,34
2025e6.6637,16
2024e5.3646,17
20235.3346,42
20229.9626,61
20216.7824,63
20208.0388,92
20191.1723,93
20181.4654,79
20174.0392,80
20163.1971,79
20155.4183,55
20146.9871,49
20136.4889,66
20127.0187,02

Arcadia Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Arcadia Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Arcadia Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Arcadia Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Arcadia Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Arcadia Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Arcadia Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Arcadia Biosciences’s growth potential.

Arcadia Biosciences Revenue, EBIT and net profit per share

DateArcadia Biosciences RevenueArcadia Biosciences EBITArcadia Biosciences Net Income
2026e7.65 M undefined0 undefined-3.11 M undefined
2025e6.66 M undefined-6.07 M undefined-1.78 M undefined
2024e5.36 M undefined-7.28 M undefined-1.95 M undefined
20235.33 M undefined-13.42 M undefined-13.98 M undefined
20229.96 M undefined-16.84 M undefined-15.38 M undefined
20216.78 M undefined-24.09 M undefined-14.66 M undefined
20208.03 M undefined-17.22 M undefined-4.66 M undefined
20191.17 M undefined-19.38 M undefined-28.81 M undefined
20181.46 M undefined-16.87 M undefined-13.48 M undefined
20174.03 M undefined-14.32 M undefined-15.71 M undefined
20163.19 M undefined-18.62 M undefined-19.62 M undefined
20155.41 M undefined-15.56 M undefined-20.73 M undefined
20146.98 M undefined-15.15 M undefined-22.08 M undefined
20136.48 M undefined-10.57 M undefined-13.2 M undefined
20127.01 M undefined-10.13 M undefined-12.37 M undefined

Arcadia Biosciences stock margins

The Arcadia Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Arcadia Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Arcadia Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Arcadia Biosciences's sales revenue. A higher gross margin percentage indicates that the Arcadia Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Arcadia Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Arcadia Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Arcadia Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Arcadia Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Arcadia Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Arcadia Biosciences Margin History

Arcadia Biosciences Gross marginArcadia Biosciences Profit marginArcadia Biosciences EBIT marginArcadia Biosciences Profit margin
2026e46.42 %0 %-40.62 %
2025e46.42 %-91.11 %-26.67 %
2024e46.42 %-135.89 %-36.38 %
202346.42 %-251.8 %-262.31 %
202226.61 %-169.08 %-154.42 %
202124.63 %-355.31 %-216.22 %
202088.92 %-214.45 %-58.03 %
201923.93 %-1,656.41 %-2,462.39 %
201854.79 %-1,155.48 %-923.29 %
201792.8 %-355.33 %-389.83 %
201671.79 %-583.7 %-615.05 %
201583.55 %-287.62 %-383.18 %
201471.49 %-217.05 %-316.33 %
201389.66 %-163.12 %-203.7 %
201287.02 %-144.51 %-176.46 %

Arcadia Biosciences Aktienanalyse

What does Arcadia Biosciences do?

Arcadia Biosciences, Inc. is a California-based company specializing in agricultural biotechnology. The company was founded in 2002 with the goal of improving and making agriculture more sustainable. Arcadia Biosciences focuses on developing plants that are more resistant to external influences such as drought or diseases, resulting in higher yields. In 2003, Arcadia Biosciences entered into a partnership with Monsanto, one of the world's largest producers of pesticides and seeds. This partnership aimed to advance the development of plants that require less pesticides and water, enabling more sustainable agricultural production. In 2008, Arcadia Biosciences acquired seed producer IPFRI, increasing production capacity and accelerating the development of new plant varieties. In 2014, the company went public on the NASDAQ stock exchange under the ticker symbol RKDA. Since then, Arcadia Biosciences has formed additional partnerships and expanded its product range. The company's core business involves developing plant varieties that are resistant to diseases and environmental influences. Arcadia Biosciences utilizes a combination of genetic and conventional breeding methods to modify the genetic makeup of plants, enhancing or weakening certain traits. This approach allows for the development of plants that are less susceptible to pests or heat. As a partner to farmers and food manufacturers, Arcadia Biosciences also provides consulting and training to promote more sustainable agricultural production. Arcadia Biosciences is divided into three business segments: 1. Arcadia Specialty Genomics: This segment specializes in the development of plants with specific traits, such as higher nutrient content or enhanced resistance to diseases. 2. GoodWheat: Under this brand, Arcadia Biosciences sells wheat products that offer a healthier alternative to conventional wheat products due to their ingredients, such as higher fiber or protein content. 3. Hemp: This segment focuses on the development of hemp products, including oil-rich seeds or hemp seeds as superfoods. Arcadia Biosciences offers a variety of products aimed at improving agricultural production and nutrition. Some examples include NitroBoost, a fertilizer that reduces nitrogen loss and improves nutrient uptake in plants; GoodWheat flour, which contains more fiber and protein than conventional wheat flour and is suitable for baking and cooking; ArcaTech, a technology designed to facilitate crop cultivation in areas with limited access to water and nutrients; and hemp seeds, which are rich in essential fatty acids and proteins. In conclusion, Arcadia Biosciences is a company specializing in agricultural biotechnology. Through the development of plants that are resistant to diseases and environmental influences, the company aims to enable more sustainable agricultural production. Arcadia Biosciences has established itself as an important player in the agricultural industry through partnerships and product development. Arcadia Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Arcadia Biosciences's Sales Figures

The sales figures of Arcadia Biosciences originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Arcadia Biosciences’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Arcadia Biosciences's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Arcadia Biosciences’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Arcadia Biosciences stock

How much revenue did Arcadia Biosciences generate this year?

Arcadia Biosciences has achieved a revenue of 5.36 M USD this year.

How much was the turnover of the company Arcadia Biosciences compared to the previous year?

The revenue of Arcadia Biosciences has increased by 0.53% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Arcadia Biosciences?

The revenue of Arcadia Biosciences is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Arcadia Biosciences measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Arcadia Biosciences so important for investors?

The revenue of Arcadia Biosciences is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Arcadia Biosciences pay?

Over the past 12 months, Arcadia Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcadia Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcadia Biosciences?

The current dividend yield of Arcadia Biosciences is .

When does Arcadia Biosciences pay dividends?

Arcadia Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcadia Biosciences?

Arcadia Biosciences paid dividends every year for the past 0 years.

What is the dividend of Arcadia Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcadia Biosciences located?

Arcadia Biosciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Arcadia Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcadia Biosciences from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Arcadia Biosciences pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Arcadia Biosciences in the year 2023?

In the year 2023, Arcadia Biosciences distributed 0 USD as dividends.

In which currency does Arcadia Biosciences pay out the dividend?

The dividends of Arcadia Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Arcadia Biosciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Arcadia Biosciences

Our stock analysis for Arcadia Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arcadia Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.